Sorry, you need to enable JavaScript to visit this website.

METHOTREXATE (methotrexate) Health Professional Information

Pfizer recognizes the public concern in relation to COVID-19, which continues to evolve. Click here to learn how we are responding.
Pfizer reconnaît les préoccupations du grand public concernant la situation liée à la COVID-19, qui continue d'évoluer. Cliquez ici pour savoir comment nous avons réagi.

Health Professional Information

SUMMARY PRODUCT INFORMATION

Route of
Administration
Dosage Form / StrengthClinically Relevant Nonmedicinal
Ingredients
Intramuscular, intravenous, intra-arterial, intrathecal, intraventricularSterile solution (preservative-free) /
10 mg/mL (20 mg/2 mL)
25 mg/mL (50 mg/2 mL)
For a complete listing see DOSAGE FORMS, COMPOSITION AND PACKAGING section.
Intravenous Sterile solution (Pharmacy Bulk vial; preservative-free) /
25 mg/mL (500 mg/20 mL; 1 g/40 mL; 2.5 g/100 mL)
For a complete listing see DOSAGE FORMS, COMPOSITION AND PACKAGING section.
Intramuscular, intravenous, intra-arterial

Sterile solution (with preservative) /
25 mg/mL (50 mg/2 mL; 500 mg/20 mL)

Benzyl alcohol as preservative

For a complete listing see DOSAGE FORMS, COMPOSITION AND PACKAGING section.

What's New

No Current Announcements.

Contact Pfizer Medical Information

Report an Adverse Event
1 866 723-7111